RRM2


Summary: This gene encodes one of two non-identical subunits for ribonucleotide reductase. This reductase catalyzes the formation of deoxyribonucleotides from ribonucleotides. Synthesis of the encoded protein (M2) is regulated in a cell-cycle dependent fashion. Transcription from this gene can initiate from alternative promoters, which results in two isoforms that differ in the lengths of their N-termini. Related pseudogenes have been identified on chromosomes 1 and X. [provided by RefSeq, Sep 2009].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

Gene Categories:

DRUGGABLE GENOME

GO terms in RRM2


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
CC IBA GO:0005829 cytosol
CC IDA GO:0005829 cytosol
CC TAS GO:0005829 cytosol
BP TAS GO:0000083 regulation of transcription involved in G1/S transition of mitotic cell cycle
BP IEA GO:0006260 DNA replication
BP IBA GO:0009263 deoxyribonucleotide biosynthetic process
Showing 1 to 6 of 14 rows rows per page

Gene expression in normal tissue: RRM2

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in RRM2


Loading, please wait...
Database
Pathway ID
Pathway Des.
reactome R-HSA-1430728 Metabolism
reactome R-HSA-15869 Metabolism of nucleotides
reactome R-HSA-1640170 Cell Cycle
reactome R-HSA-212436 Generic Transcription Pathway
reactome R-HSA-453279 Mitotic G1-G1/S phases
reactome R-HSA-499943 Interconversion of nucleotide di- and triphosphates
Showing 1 to 6 of 59 rows rows per page

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD79 Gemcitabine 1
iGMDRD517 17224927 1
Showing 1 to 2 of 2 rows

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in RRM2

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​